Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
$4-bil market opportunity in dyskinesia
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Nuveen is a global investment leader, managing an array of public and private assets for clients around the world and on behalf of our parent company TIAA , one of the world’s largest institutional investors,1 a highly-rated2 insurance company and a retir
00:10:00
PIC CEO Abel Reflects on Asset Growth, Market Recovery, and Social Impact Amidst Pandemic Turbulence | Abel Sithole, CEO , Public Investment Corporation.
00:00:00
Sloan Devlin, Ph.D. Associate Professor of Biological Chemistry and Molecular Pharmacology, HMS | How the Gut Microbiome Affects Health and Disease
00:10:00
Navigating Waste Management: Insights from Waste Management, Inc. CEO
00:10:00
Investing Along the Z-Axis with Airbus Ventures|Lewis Pinault,Partner,Asia Japan & The Pacific,Airbus Ventures
00:00:00
David McNally, CEO | Titan Medical Inc.
00:10:00
Charles Lehman on Urban Policy and the Jordan Neely Case|Charles Fain Lehman,Professor,Manhattan Institute
00:10:00
Yellowcake PLC CEO Andre Liebenberg Discusses Company Strategy and Uranium Market
00:10:00
The bold entrepreneurs building the future|Kristina Shen,General Partner,Andreessen Horowitz
00:10:00
Q1 2024 Market Review: Strong Returns, Persistent Inflation, and Federal Reserve Outlook
00:10:00
Innovative Pharmaceutical Company Accelerates Growth and Forges Strategic Partnerships |Hartley Atkinson, CEO, AFT Pharmaceuticals Ltd .
00:10:00
Educational Insights into Value Investing: Uncovering Undervalued Stocks and Giving Back to Society|Donna Manson,CEO,Devon Value Advisers